Fluidx Completes Follow-Up in Multicenter Study of GPX Liquid Embolic Agent

October 6, 2022—Fluidx Medical announced the completion of follow-up in its multicenter clinical trial examining the broad application of the co

Related Keywords

Auckland ,New Zealand ,Andrew Holden ,Martin Krauss ,Society Of Interventional Radiology ,Fluidx Medical ,Interventional Radiology ,Christchurch Hospital ,Principal Investigator ,Auckland City Hospital ,Global Embolization Symposium ,Leipzig Interventional ,Multicenter Clinical Trial ,Spx ,Liquid Embolic Agent ,Embolization ,Low Viscosity ,Queous Based ,Occlusion ,Ncology ,Ravenous ,